- Home
- CVRX
CVRX
CVRx Inc.
as 06-20-2025 3:34pm EST
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
| Founded: | 2000 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 174.4M | IPO Year: | 2021 |
| Target Price: | $14.50 | AVG Volume (30 days): | 232.7K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.17 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.30 - $18.55 | Next Earning Date: | 07-28-2025 |
| Revenue: | $52,870,000 | Revenue Growth: | 25.62% |
| Revenue Growth (this year): | 11.53% | Revenue Growth (next year): | 18.61% |
Stock Insider Trading Activity of CVRx Inc. (CVRX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | CVRX | Director | May 15 '25 | Buy | $5.45 | 10,966 | $59,795.40 | 1,910,134 | |
| Hykes Kevin | CVRX | PRES & CEO | May 12 '25 | Buy | $4.84 | 5,000 | $24,200.00 | 133,000 | |
| Jain Mudit K. | CVRX | Director | May 12 '25 | Buy | $4.96 | 1,650 | $7,774.95 | 4,900 | |
| Nielsen Kirk G. | CVRX | Director | May 12 '25 | Buy | $5.10 | 187,813 | $977,346.35 | 1,910,134 |
Latest CVRx Inc. News
CVRX Breaking Stock News: Dive into CVRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
24 days ago
CVRx to Present at the William Blair 45th Annual Growth Stock Conference
GuruFocus.com
a month ago
CVRx Inc (CVRX) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Sales Force Realignment ...
Zacks
a month ago
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates
Associated Press Finance
a month ago
CVRx: Q1 Earnings Snapshot
GlobeNewswire
a month ago
CVRx Reports First Quarter 2025 Financial and Operating Results
GuruFocus.com
a month ago
What To Expect From CVRx Inc (CVRX) Q1 2025 Earnings
Zacks
2 months ago
CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
GlobeNewswire
2 months ago
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
Compare CVRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CVRX CVRx Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.